News

TEL AVIV, Israel--(BUSINESS WIRE)--Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure (HF), today announced results of VECTOR-HF I ...
The results of the VECTOR-HF I study will be presented at the prestigious Late-Breaking Trials session during the European Society of Cardiology Heart Failure 2022 conference in Madrid ...